Expand INDV Menu
INDV MENU

INDV Latest Press Releases

-- August 7, 2026 --

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN Business Wire 11:21 AM

-- August 3, 2026 --

Halper Sadeh LLC is Investigating Whether LNTH, ATKR, INDV are Obtaining Fair Deals for their Shareholders Globe Newswire 5:07 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) PRNewswire 3:15 PM
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 10:44 AM
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance Globe Newswire 6:31 AM
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale Globe Newswire 6:30 AM

-- July 23, 2026 --

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast Globe Newswire 10:00 AM

-- May 20, 2026 --

New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization Globe Newswire 9:00 AM

-- May 14, 2026 --

Indivior to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- May 4, 2026 --

Indivior Announces $175 Million Accelerated Share Repurchase Globe Newswire 7:00 AM

-- April 30, 2026 --

Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance Globe Newswire 7:00 AM

-- April 24, 2026 --

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder Globe Newswire 11:00 AM

-- April 16, 2026 --

Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse Globe Newswire 2:30 PM

-- April 9, 2026 --

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th Globe Newswire 7:00 AM

-- March 31, 2026 --

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes